Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases
- PMID: 21342722
- DOI: 10.1016/j.remn.2010.10.008
Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases
Abstract
A 62 year-old male with prostate cancer, recently complaining lumbar pain with elevated PSA level (6.83 ng/ml) was referred for evaluating bone metastases. Bone scintigraphy with (99m)Tc-MDP demonstrated intense uptake on third lumbar vertebra. Postoperative biopsy of the lesion on third lumbar vertebra revealed adenocarcinoma metastasis. For evaluating distant metastases and restaging, (18)F-FDG PET-CT was performed postoperatively. On PET-CT imaging there were cervical and left parailiac lymph nodes with FDG uptake, destruction on third lumbar vertebra level and intense soft tissue mass FDG uptake on the same area. Additionally, FDG uptake was detected on right iliac crest. On the CT images obtained by integrated PET-CT scanner, this uptake was matching with lytic bone metastases. The superiority of (18)F-FDG PET-CT for demonstrating osteolytic bone metastases compared to bone scintigraphy was presented in a case of prostate cancer in a patient with bone and lymph node metastases.
Copyright © 2010 Elsevier España, S.L. and SEMNIM. All rights reserved.
Similar articles
-
[PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].Rev Esp Med Nucl. 2009 May-Jun;28(3):95-100. Rev Esp Med Nucl. 2009. PMID: 19558948 Clinical Trial. Spanish.
-
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.J Nucl Med. 2002 Jan;43(1):46-55. J Nucl Med. 2002. PMID: 11801702
-
Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16. Eur J Cardiothorac Surg. 2010. PMID: 20015657
-
Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.Medicine (Baltimore). 2023 Jul 14;102(28):e34196. doi: 10.1097/MD.0000000000034196. Medicine (Baltimore). 2023. PMID: 37443509 Free PMC article. Review.
-
Positron emission tomography and bone metastases.Semin Nucl Med. 2005 Apr;35(2):135-42. doi: 10.1053/j.semnuclmed.2004.11.005. Semin Nucl Med. 2005. PMID: 15765376 Review.
Cited by
-
Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy.Indian J Nucl Med. 2013 Jul;28(3):178-9. doi: 10.4103/0972-3919.119545. Indian J Nucl Med. 2013. PMID: 24250030 Free PMC article.
-
PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.Theranostics. 2017 May 15;7(7):2048-2064. doi: 10.7150/thno.19883. eCollection 2017. Theranostics. 2017. PMID: 28656060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous